Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-25

Clinical Trial Update: An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating an exercise program for patients with acute myeloid leukemia undergoing induction chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Health Network, Toronto | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED